Astria Therapeutics, Inc. (ATXS) Insider Trading

Name: Astria Therapeutics, Inc. (ATXS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jan 23, 2026): Jonathan Violin (Director): Disposition to Issuer of 263,321 shares.

Get alerted when insiders trade ATXS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta